Form 13-F position report

BOSTON SCIENTIFIC CORP

Reported by Legal & General Group Plc

BSX CUSIP 101137107 Manager CIK 0000764068

Reported 11,166,177 shares, up 409,391 (3.8%) from the prior quarter.

Reported value -12.6%; share count 3.8% vs. the prior quarter.

Added
% of reported 13F value 0.15% This manager · Q2 2022
Shares 11,166,177 Quarter-end amount reported
Reported value $416,163,000 Fair value at quarter end
Consecutive quarters held 37 Through Q2 2022

Reported position value by quarter

Reported position value by quarter

Each bar is a Form 13-F quarter-end snapshot. It does not show trades made within the quarter.

Reported position value by quarter
Date Holding Value
2021-09-30 445807000
2021-12-31 419527000
2022-03-31 476418000
2022-06-30 416163000
2022-09-30 420049000
2022-12-31 487035563
2023-03-31 538443342
2023-06-30 622301039
2023-09-30 594178428
2023-12-31 657584484
2024-03-31 782118512
2024-06-30 877430842
2024-09-30 933410516
2024-12-31 959190141
2025-03-31 1096372313
2025-06-30 1073378837
2025-09-30 1020934001
2025-12-31 1037085420
2026-03-31 665198075
2026-06-30 431890184

Quarterly position history

How this manager's reported quarter-end position changed over time.

20 quarters
Quarterly reported position history for BOSTON SCIENTIFIC CORP held by Legal & General Group Plc.
Quarter Activity Shares Change % of reported 13F Reported value Filed Source filing
Q2 2026 Reduced 10,119,264 -481,502 (-4.5%) 0.09% $431,890,184 2026-08-14
Q1 2026 Reduced 10,600,766 -275,851 (-2.5%) 0.15% $665,198,075 2026-05-08
Q4 2025 Added 10,876,617 +419,442 (4.0%) 0.23% $1,037,085,420 2026-02-09
Q3 2025 Added 10,457,175 +463,889 (4.6%) 0.23% $1,020,934,001 2025-11-13
Q2 2025 Reduced 9,993,286 -874,798 (-8.0%) 0.27% $1,073,378,837 2025-08-12
Q1 2025 Added 10,868,084 +129,278 (1.2%) 0.3% $1,096,372,313 2025-05-15
Q4 2024 Reduced 10,738,806 -399,753 (-3.6%) 0.25% $959,190,141 2025-02-13
Q3 2024 Reduced 11,138,559 -255,140 (-2.2%) 0.25% $933,410,516 2024-11-14
Q2 2024 Reduced 11,393,699 -25,761 (-0.2%) 0.25% $877,430,842 2024-08-14
Q1 2024 Added 11,419,460 +44,544 (0.4%) 0.23% $782,118,512 2024-05-14
Q4 2023 Added 11,374,916 +121,548 (1.1%) 0.2% $657,584,484 2024-02-15
Q3 2023 Reduced 11,253,368 -251,576 (-2.2%) 0.21% $594,178,428 2023-11-14
Q2 2023 Added 11,504,944 +742,518 (6.9%) 0.2% $622,301,039 2023-08-14
Q1 2023 Added 10,762,426 +236,481 (2.2%) 0.19% $538,443,342 2023-05-15
Q4 2022 Reduced 10,525,945 -319,607 (-2.9%) 0.19% $487,035,563 2023-02-14
Q3 2022 Reduced 10,845,552 -320,625 (-2.9%) 0.16% $420,049,000 2022-11-14
Q2 2022 Added 11,166,177 +409,391 (3.8%) 0.15% $416,163,000 2022-08-22
Q1 2022 Added 10,756,786 +880,914 (8.9%) 0.14% $476,418,000 2022-05-16
Q4 2021 Reduced 9,875,872 -398,544 (-3.9%) 0.13% $419,527,000 2022-02-14
Q3 2021 Added 10,274,416 +551,217 (5.7%) 0.14% $445,807,000 2021-11-15
Five years are shown. A free account unlocks the complete reported history. Unlock full history

Who else reported the position

947 managers reported BOSTON SCIENTIFIC CORP for Q2 2022.

Managers reporting BOSTON SCIENTIFIC CORP in Q2 2022.
Manager Activity Shares Change % of reported 13F Reported value Tenure
BlackRock Inc Reduced 126,258,034 -175,254 0.15% $4,705,638,000 37 qtrs
VANGUARD GROUP INC Added 115,177,740 +1,812,913 0.12% $4,292,675,000 37 qtrs
MASSACHUSETTS FINANCIAL SERVICES CO MA Reduced 83,605,616 -563,369 1.07% $3,115,981,000 16 qtrs
FMR LLC Reduced 77,968,047 -15,151,332 0.29% $2,905,869,000 37 qtrs
STATE STREET CORPORATION Added 63,670,965 +447,651 0.14% $2,373,017,000 37 qtrs
WELLINGTON MANAGEMENT GROUP LLP Reduced 63,660,026 -4,679,386 0.48% $2,372,609,000 37 qtrs
JPMorgan Chase & Co Added 51,509,775 +3,738,113 0.27% $1,919,770,000 37 qtrs
PRIMECAP MANAGEMENT CO CA Reduced 37,819,609 -101,210 1.26% $1,409,537,000 37 qtrs
Bollard Group LLC Reduced 26,195,991 -437,881 39.56% $976,325,000 37 qtrs
JANUS HENDERSON GROUP PLC Reduced 26,045,094 -707,854 0.67% $970,705,000 37 qtrs
Premium adds each manager's conviction percentile across reporting peers.
Filing details and methodology As reported
Report period
June 30, 2022
Filed
August 22, 2022
Filing type
13F-HR
Position type
COM

Voting authority reported

Sole
8,986,546
Shared
0
None
2,179,631

“None” means the manager reported no voting authority for those shares on non-routine matters. It does not disclose why and is not evidence of securities lending.

Form 13-F is a delayed quarter-end snapshot of disclosed long Section 13(f) securities. It can be filed up to 45 days after quarter end, excludes short positions and most non-U.S. securities, and does not reveal intra-quarter trading. For options, reported shares and value describe the underlying-share exposure; strike, expiry, premium, and written positions are not disclosed.